Cargando…
Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine
[Image: see text] Radiotherapy and immunotherapy are two key treatments for cancer. There is growing evidence that they are also synergistic, and combination treatments are being studied extensively in the clinical setting. In addition, there is emerging evidence that nanotechnology-enabled therapeu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747221/ https://www.ncbi.nlm.nih.gov/pubmed/33251789 http://dx.doi.org/10.1021/acs.bioconjchem.0c00520 |
_version_ | 1783624932901519360 |
---|---|
author | Hagan, C. Tilden Mi, Yu Knape, Nicole M. Wang, Andrew Z. |
author_facet | Hagan, C. Tilden Mi, Yu Knape, Nicole M. Wang, Andrew Z. |
author_sort | Hagan, C. Tilden |
collection | PubMed |
description | [Image: see text] Radiotherapy and immunotherapy are two key treatments for cancer. There is growing evidence that they are also synergistic, and combination treatments are being studied extensively in the clinical setting. In addition, there is emerging evidence that nanotechnology-enabled therapeutics can potentiate both radiotherapy and immunotherapy, in turn improving both treatments. This is an exciting new area of interdisciplinary science and has significant potential for major clinical impact. Some of the approaches in this area have already reached the clinical stage. In this review, we will discuss recent advances in the interface between radiotherapy, immunotherapy, and nanomedicine. We plan to review the many approaches to combine these three fields for cancer treatment. |
format | Online Article Text |
id | pubmed-7747221 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | American Chemical
Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-77472212020-12-18 Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine Hagan, C. Tilden Mi, Yu Knape, Nicole M. Wang, Andrew Z. Bioconjug Chem [Image: see text] Radiotherapy and immunotherapy are two key treatments for cancer. There is growing evidence that they are also synergistic, and combination treatments are being studied extensively in the clinical setting. In addition, there is emerging evidence that nanotechnology-enabled therapeutics can potentiate both radiotherapy and immunotherapy, in turn improving both treatments. This is an exciting new area of interdisciplinary science and has significant potential for major clinical impact. Some of the approaches in this area have already reached the clinical stage. In this review, we will discuss recent advances in the interface between radiotherapy, immunotherapy, and nanomedicine. We plan to review the many approaches to combine these three fields for cancer treatment. American Chemical Society 2020-11-30 2020-12-16 /pmc/articles/PMC7747221/ /pubmed/33251789 http://dx.doi.org/10.1021/acs.bioconjchem.0c00520 Text en © 2020 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Hagan, C. Tilden Mi, Yu Knape, Nicole M. Wang, Andrew Z. Enhancing Combined Immunotherapy and Radiotherapy through Nanomedicine |
title | Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine |
title_full | Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine |
title_fullStr | Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine |
title_full_unstemmed | Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine |
title_short | Enhancing Combined Immunotherapy and Radiotherapy
through Nanomedicine |
title_sort | enhancing combined immunotherapy and radiotherapy
through nanomedicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747221/ https://www.ncbi.nlm.nih.gov/pubmed/33251789 http://dx.doi.org/10.1021/acs.bioconjchem.0c00520 |
work_keys_str_mv | AT haganctilden enhancingcombinedimmunotherapyandradiotherapythroughnanomedicine AT miyu enhancingcombinedimmunotherapyandradiotherapythroughnanomedicine AT knapenicolem enhancingcombinedimmunotherapyandradiotherapythroughnanomedicine AT wangandrewz enhancingcombinedimmunotherapyandradiotherapythroughnanomedicine |